Functional mapping of protective epitopes within the rotavirus VP6 protein in mice belonging to different haplotypes

Vaccine

Volumn 21, Issue 7-8, 2003, Pages 761-767

  Choi, Anthony H C ^a   McNeal, Monica M ^a   Basu, Mitali ^a   Bean, Judy A ^a   VanCott, John L ^a   Clements, John D ^b   Ward, Richard L ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b TULANE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Rotavirus; Subunit vaccine; Synthetic peptide

Indexed keywords

EPITOPE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; SUBUNIT VACCINE; VIRUS PROTEIN;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ASSAY; CONFERENCE PAPER; CONTROLLED STUDY; EPITOPE MAPPING; FEMALE; HAPLOTYPE; IMMUNIZATION; MOUSE; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTECTION; ROTAVIRUS; STATISTICAL ANALYSIS;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, VIRAL; CAPSID PROTEINS; EPITOPE MAPPING; FEMALE; HAPLOTYPES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED DBA; MOLECULAR SEQUENCE DATA; SPECIES SPECIFICITY;

EID: 0037472432     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(02)00595-9     Document Type: Conference Paper

References (18)

1. Parashar UD, Hummelman EG, Bresee JS, Miller MA, Glass RG. In: Proceedings of the Conference on Vaccines for Enteric Diseases, Tampere, Finland, 2001 [Abstract].
2. World Health Organization. Rotavirus vaccines. Weekly Epidemiol Rec 1999;74:33-40.
3. Murphy T.V., Gargiullo P.M., Massoudi M.S., Nelson D.B., Jumaan A.O.et al. Rotavirus intussusception investigation team: intussusception among infants given an oral rotavirus vaccine. N. Engl. J. Med. 344:2001;564-572.
4. Choi A.H., Basu M., McNeal M.M., Clements J.D., Ward R.L. Antibody-independent protection against rotavirus infection of mice stimulated by intranasal immunization with chimeric VP4 or VP6 protein. J. Virol. 73:1999;7574-7581.
5. Choi A.H., Basu M.M.M.et al. Functional mapping of protective domains and epitopes in the rotavirus VP6 protein. J. Virol. 74:2000;11574-11580.
6. Choi A.H., McNeal M.M., Flint J.A., Basu M., Lycke N.Y.et al. The level of protection against rotavirus shedding in mice following immunization with a chimeric VP6 protein is dependent on the route and the coadministered adjuvant. Vaccine. 15(20):2002;1733-1740.
7. Choi A.H.C., Monica M.M., Basu M., Flint J.A., Stone S.C.et al. Intranasal or oral immunization of inbred and outbred mice with murine or human rotavirus VP6 proteins protects against viral shedding after challenge with murine rotaviruses. Vaccine. 3325:2002;1-12.
8. McNeal M.M., VanCott J.L., Choi A.H.C., Basu M., Flint J.A.et al. CD4 T cells are the only lymphocytes needed to elicit protection of mice against rotavirus shedding following intranasal immunization with a chimeric VP6 protein. J. Virol. 76:2002;560-568.
9. Choi A.H., Basu M., Rae M.N., McNeal M.M., Ward R.L. Particle-bombardment-mediated DNA vaccination with rotavirus VP4 or VP7 induces high levels of serum rotavirus IgG but fails to protect mice against challenge. Virology. 250:1998;230-240.
10. Tang B., Gilbert J.M., Matsui S.M., Greenberg H.B. Comparison of the rotavirus gene 6 from different species by sequence analysis and localization subgroup-specific epitopes using site-directed mutagenesis. Virology. 237:1997;89-96.
11. Banos D.M., Lopez S., Arias C.F., Esquivel F.R. Identification of a T-helper cell epitope on the rotavirus VP6 protein. J. Virol. 71:1997;419-426.
12. Arnold P.Y., La Gruta N.L., Miller T., Vignali K.M., Adams P.S.et al. The majority of immunogenic epitopes generate CD4(+) T Cells that are dependent on MHC class II-bound peptide-flanking residues. J. Immunol. 169:2002;739-749.
13. Franco M.A., Prieto I., Labbe M., Poncet D., Borras-Cuesta F., Cohen J. An immunodominant cytotoxic T cell epitope on the VP7 rotavirus protein overlaps the H2 signal peptide. J. Gen. Virol. 74:1993;2579-2586.
14. Franco M.A., Lefevre P., Willems P., Tosser G., Lintermanns P., Cohen J. Identification of cytotoxic T cell epitopes on the VP3 and VP6 rotavirus proteins. J. Gen. Virol. 75:1994;589-596.
15. Falk K., Rotzschke O., Stevanovic S., Jung G., Rammensee H.G. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature. 351:1991;290-296.
16. Rammensee H., Bachmann J., Emmerich N.P., Bachor O.A., Stevanovic S. SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics. 50:1999;213-219.
17. Knights A.J., Zaniou A., Rees R.C., Pawelec G., Muller L. Prediction of an HLA-DR-binding peptide derived from Wilms' tumour 1 protein and demonstration of in vitro immunogenicity of WT1 (124-138)-pulsed dendritic cells generated according to an optimised protocol. Cancer Immunol. Immunother. 51:2002;271-281.
18. Pietersz G.A., Li W., Apostolopoulos V. A 16-mer peptide (RQIKIWFQNRRMKWKK) from antennapedia preferentially targets the class I pathway. Vaccine. 19:2001;1397-1405.